Skip to Content

Cipla 422 100 mg (Celecoxib 100 mg)

Pill with imprint Cipla 422 100 mg is White, Capsule-shape and has been identified as Celecoxib 100 mg. It is supplied by Cipla USA Inc..

Celecoxib is used in the treatment of osteoarthritis; ankylosing spondylitis; familial adenomatous polyposis; juvenile rheumatoid arthritis; migraine and belongs to the drug class cox-2 inhibitors. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 422 100 mg

Celecoxib

Imprint
Cipla 422 100 mg
Strength
100 mg
Color
White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cox-2 inhibitors
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0422
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone, sodium lauryl sulfate, gelatin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.